ArticleActa pharmaceutica Sinica. B2026
Engineering an immuno-nanoprodrug: Photo-controlled pyroptosis synergizing with acid-activatable immunometabolic blockade for potent cancer immunotherapy.
Zhiliang Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.